Contura International Ltd

Contura International Ltd is a private limited company based in London, UK, with a manufacturing facility in Copenhagen, Denmark. Founded in January 2021, the company operates in the pharmaceutical and medical device sectors, focusing on the development and manufacture of hydrogel-based products for medical applications. Contura specializes in patented hydrogel technologies that are non-absorbable and highly durable. Its product portfolio includes Arthrosamid® for knee osteoarthritis, Bulkamid® for female urinary incontinence, Aquamid® for facial augmentation, and Arthramid Vet for veterinary use. The company serves healthcare providers and hospitals in Europe and the US, as well as the veterinary market through Contura Vet. It has established partnerships with major healthcare companies, including Johnson & Johnson’s Ethicon subsidiary. To meet growing demand, Contura has expanded its Copenhagen facility and continues to invest in clinical trials and product development. The company aims to fulfill over 1 million doses by 2026, reinforcing its commitment to innovative healthcare solutions.

• Employees 40
• Founded 2000
• Annual Revenue $7000000
• Total Funding $7236275